These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 996046)

  • 41. Blockade of peripheral beta-adrenergic receptors fails to suppress the cerebral spread of an engram in mice.
    Church AC; Flexner JB; Flexner LB; Rainbow TC
    Pharmacol Biochem Behav; 1985 Jul; 23(1):27-31. PubMed ID: 2994119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adrenalectomy and the suppression of memory by puromycin.
    Flexner JB; Flexner LB
    Proc Natl Acad Sci U S A; 1970 May; 66(1):48-52. PubMed ID: 4320463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased dopamine concentration in the striatum in the mouse by FLA-63, a dopamine- -hydroxylase inhibitor.
    Svensson TH
    J Pharm Pharmacol; 1973 Jan; 25(1):73-5. PubMed ID: 4146204
    [No Abstract]   [Full Text] [Related]  

  • 44. Interference of inhibitors of dopamine-beta-hydroxylase with uptake of monoamines by chromaffin granular membranes.
    Schlichter D; Da Prada M; Pletscher A
    Eur J Pharmacol; 1975 Nov; 34(1):223-7. PubMed ID: 187432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antagonism by DL-threo-DOPS of the suppression of a conditioned avoidance response induced by a dopamine-beta-hydroxylase inhibitor.
    Ahlenius S; Engel J
    J Neural Transm; 1973; 34(4):267-77. PubMed ID: 4359658
    [No Abstract]   [Full Text] [Related]  

  • 46. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
    Kato T; Katsuyama M; Karai N; Nakamura M; Katsube J
    Pharmacol Biochem Behav; 1987 Feb; 26(2):407-11. PubMed ID: 3106991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.
    Berger T; Lemmer B
    Pol J Pharmacol Pharm; 1976; 28(6):601-3. PubMed ID: 1012983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Norepinephrine-dopamine interactions and behavior.
    Antelman SM; Caggiula AR
    Science; 1977 Feb; 195(4279):646-53. PubMed ID: 841304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in the content and turnover of noradrenaline in rat heart atria and ventricles and circadian-phase-dependency.
    Lemmer B; Weimer R
    Experientia; 1983 Sep; 39(9):998-1000. PubMed ID: 6884497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of dopamine-beta-hydroxylase inhibitors, dimethylphenylthiourea and fusaric acid, on locomotor and exploratory activity, body temperature, and regional distribution of biogenic amines in the rat brain.
    Vetulani J; Reichenberg K; wiszniowska G; Marchaj J
    Pol J Pharmacol Pharm; 1973; 25(6):559-72. PubMed ID: 4792476
    [No Abstract]   [Full Text] [Related]  

  • 52. Pituitary peptides and the suppression of memory by puromycin.
    Flexner JB; Flexner LB
    Proc Natl Acad Sci U S A; 1971 Oct; 68(10):2519-21. PubMed ID: 4332813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of FLA-63, p-chlorophenylalanine and pimozide on the metabolism and incorporation of 3H-thymidine in the brain of rat pups.
    Béndek G
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):203-10. PubMed ID: 6225149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of 1-phenyl-3-(2-thiazolyl)-2-thiourea, a dopamine beta-hydroxylase inhibitor on morphine analgesia, tolerance and physical dependence.
    Bhargava HN; Way EL
    J Pharmacol Exp Ther; 1974 Jul; 190(1):165-75. PubMed ID: 4858783
    [No Abstract]   [Full Text] [Related]  

  • 55. Dopamine-beta-hydroxylase inhibitors, feeding and locomotor activity: reinstatement of feeding following central norepinephrine.
    Evans KR; Beninger RJ; Eikelboom R
    Pharmacol Biochem Behav; 1985 Apr; 22(4):535-40. PubMed ID: 3991764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complementary memory storage sites in mice: their development as affected by the competitive NMDA receptor antagonist, CPP.
    Church AC; Flexner JB; Flexner LB
    Pharmacol Biochem Behav; 1995 Sep; 52(1):237-40. PubMed ID: 7501672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Puromycin effect on memory may be due to occult seizures.
    Cohen HD; Barondes SH
    Science; 1967 Jul; 157(3786):333-4. PubMed ID: 6067547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term suppression of the cerebral spread of a memory: effects of idazoxan and clonidine.
    Church AC; Flexner LB; Flexner JB; Reynolds EE
    Pharmacol Biochem Behav; 1989 Mar; 32(3):749-56. PubMed ID: 2544908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors.
    Lokhandwala MF; Buckley JP
    J Pharmacol Exp Ther; 1978 Feb; 204(2):362-71. PubMed ID: 621670
    [No Abstract]   [Full Text] [Related]  

  • 60. Synthesis and biological evaluation of novel, peripherally selective chromanyl imidazolethione-based inhibitors of dopamine beta-hydroxylase.
    Beliaev A; Learmonth DA; Soares-da-Silva P
    J Med Chem; 2006 Feb; 49(3):1191-7. PubMed ID: 16451083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.